AlphaOS

Coverage building

EVO has basic price and filing data (45% intelligence coverage), but earnings analysis, financial metrics, and proprietary signals are still building. Explore a peer with deeper coverage below.

Deeper coverage nearby

Intelligence coverage: 45%

Basic profile, financials, and market data are shown below. Deep research is building in the background.

EVO

Evotec SE

Healthcare · Drug Manufacturers—Specialty & Generic

$1.54Sep 23, 2026

AI confidence 70% · prior close shown (market closed)

Investment Snapshot

Limited proprietary earnings coverage for EVO yet — signals will sharpen as filings and earnings are ingested.

Pipeline evidence · 73d ago

AlphaOS Signals
Upgrade to Premium

Latest Intelligence

Updated

What happened recently for Evotec SE (EVO) — events, not interpretation.

Event
Last session September 23, 2026 at $1.54.
Source
Market data

Research & analysis only — not investment advice.

Building company intelligence…

Evotec SE (EVO)

Healthcare · Drug Manufacturers—Specialty & Generic

Investment Snapshot above is the primary AlphaOS analysis for Evotec SE — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.

Key facts

Sector:
Healthcare
Industry:
Drug Manufacturers—Specialty & Generic
Market cap:
$273.78M

EVO earnings analysis

Research & analysis only — not investment advice. Price, charts, and filings are above.

Connected intelligence

Follow Evotec SE through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.

Themes

Related & Connected

Related

Related stock research

Connected companies and research pages from the AlphaOS knowledge graph.